Sfoglia per Rivista
Human leukocyte antigen polymorphisms in Italian primary biliary cirrhosis : a multicenter study of 664 patients and 1992 healthy controls
2008-01-01 Invernizzi, P.; Selmi, C.; Poli, F.; Frison, S.; Floreani, A.; Alvaro, D.; Almasio, P.; Rosina, F.; Marzioni, M.; Fabris, L.; Muratori, L.; Qi, L.; Seldin, M. F.; Gershwin, M. E.; Podda, M.; Andreoletti, M.; Andriulli, A.; Baldini, V.; Battezzati, P. M.; Benedetti, A.; Bernuzzi, F.; Bianchi, F. B.; Bianchi, I.; Bignotto, M.; Bragazzi, M. C.; Brunetto, M.; Caimi, M.; Caliari, L.; Caporaso, N.; Casella, G.; Casiraghi, A.; Colli, A.; Colombo, M.; Conte, D.; Croce, L.; Crosignani, A.; Dottorini, L.; Ferrari, C.; Fraquelli, M.; Frati, C. E.; Galli, A.; Lleo, A.; Mancino, M. G.; Mandelli, G.; Marra, F.; Montanari, R.; Monti, V.; Morini, L.; Morisco, F.; Niro, G.; Palasciano, G.; Calmieri, V. O.; Pasini, S.; Picciotto, A.; Portincasa, P.; Pozzoli, V.; Spinzi, G.; Strazzabosco, M.; Tiribelli, C.; Toniutto, P.; Zerminai, P.; Zuin, M.
IMMUNE CHANGES DURING THE EARLY STEPS OF HUMAN LIVER CARCINOGENESIS
2019-01-01 Meylan, M; Petitprez, F; Lacroix, L; Di Tommaso, L; Roncalli, M; Pawlotsky, Jm; Fridman, C; Fridman, Wh; Calderaro, J
Immunoglobulin M levels inversely correlate with CD40 ligand promoter methylation in patients with primary biliary cirrhosis
2012-01-01 Lleo, A; Liao, J; Invernizzi, P; Zhao, M; Bernuzzi, F; L, Ma; Lanzi, G; Ansari, Aa; Coppel, Rl; Zhang, P; Y, Li; Zhou, Z; Lu Q and Gershwin, Me.
Impaired intrahepatic natural killer cell cytotoxic function in chronic hepatitis C virus infection
2012-01-01 Varchetta, S.; Mele, D.; Mantovani, S.; Oliviero, B.; Cremonesi, E.; Ludovisi, S.; Michelone, G.; Alessiani, M.; Rosati, R.; Montorsi, M.; Mondelli, M. U.
Impairment of hepatic growth hormone and glucocorticoid receptor signaling causes steatosis and hepatocellular carcinoma in mice.
2011-01-01 Mueller, Km; Kornfeld, Jw; Friedbichler, K; Blaas, L; Egger, G; Esterbauer, H; Hasselblatt, P; Schlederer, M; Haindl, S; Wagner, Ku; Engblom, D; Haemmerle, G; Kratky, D; Sexl, V; Kenner, L; Kozlov, Av; Terracciano, L; Zechner, R; Schuetz, G; Casanova, E; Pospisilik, Ja; Heim, Mh; Moriggl, R
Increased risk of hepatocellular carcinoma in HCV (+) non responder cirrhotics with high liver cell proliferation
2008-01-01 Donato, M. F.; Arosio, E.; Aghemo, A.; Rumi, M. G.; Ronchi, G.; Colombo, M.
Inducible inactivation of Notch1 causes nodular regenerative hyperplasia in mice
2005-01-01 Croquelois, A; Blindenbacher, A; Terracciano, L; Wang, X; Langer, I; Radtke, F; Heim, Mh.
Interleukin 28B polymorphism predicts pegylated interferon plus ribavirin treatment outcome in chronic hepatitis C genotype 4
2012-01-01 De Nicola, S; Aghemo, A; Rumi, Mg; Galmozzi, E; Valenti, L; Soffredini, R; De Francesco, R; Prati, Gm; D'Ambrosio, R; Cheroni, C; Donato, Mf; Colombo, M
Interleukin 6 is important for survival after partial hepatectomy in mice
2003-01-01 Blindenbacher, A; Wang, X; Langer, I; Savino, R; Terracciano, L; Heim, Mh
Is there need for more than one IL28B single nucleotide polymorphism in hepatitis C clinical practice?
2013-01-01 Galmozzi, E; De Nicola, S; Aghemo, A; Colombo, M
JNJ-4178 (AL-335, Odalasvir, and Simeprevir) for 6 or 8 Weeks in Hepatitis C Virus-Infected Patients Without Cirrhosis: OMEGA-1
2019-01-01 Zeuzem, S; Bourgeois, S; Greenbloom, S; Buti, M; Aghemo, A; Lampertico, P; Janczewska, E; Lim, Sg; Moreno, C; Buggisch, P; Tam, E; Corbett, C; Willems, W; Vijgen, L; Fevery, B; Ouwerkerk-Mahadevan, S; Ackaert, O; Beumont, M; Kalmeijer, R; Sinha, R; Biermer, M
Keratin variants are overrepresented in primary biliary cirrhosis and associate with disease severity
2009-01-01 Zhong, B.; Strnad, P.; Selmi, C.; Invernizzi, P.; Tao, G. Z.; Caleffi, A.; Chen, M.; Bianchi, I.; Podda, M.; Pietrangelo, A.; Gershwin, M. E.; Omary, M. B.
Lack of alanine aminotransferase normalization in patients with an anti-hcv virological response during pegylated interferon and ribavirin therapy : a sub-analysis of the mist study
2009-01-01 Aghemo, A.; Rumi, M.; Prati, G. M.; D’Ambrosio, R.; De Nicola, S.; Colombo, M.
Lack of complete biochemical response in autoimmune hepatitis leads to adverse outcome: first report of the IAIHG retrospective registry
2023-01-01 Slooter, Charlotte D; van den Brand, Floris F; Lleo, Ana; Colapietro, Francesca; Lenzi, Marco; Muratori, Paolo; Kerkar, Nanda; Dalekos, George N; Zachou, Kalliopi; Lucena, M Isabel; Robles-Díaz, Mercedes; Di Zeo-Sánchez, Daniel E; Andrade, Raúl J; Montano-Loza, Aldo J; Lytvyak, Ellina; Lissenberg-Witte, Birgit I; Maisonneuve, Patrick; Bouma, Gerd; Macedo, Guilherme; Liberal, Rodrigo; de Boer, Ynto S
Large liver cell change in hepatitis B virus-related liver cirrhosis
2009-01-01 Kim, H.; Oh, B. K.; Roncalli, M.; Park, C.; Yoon, S. M.; Yoo, J. E.; Park, Y. N.
Letter to the Editor: Are We Confident That Primary Biliary Cholangitis Liver‐Related Mortality Is Higher in Males?
2021-01-01 Lleo, Ana; Hirschfield, Gideon M.
Letter to the Editor: might denosumab fit in PBC treatment?
2019-01-01 Lleo, A; Ma, X; Gershwin, Me; Invernizzi, P
Letter to the Editor: Might Denosumab Fit in Primary Biliary Cholangitis Treatment?
2020-01-01 Lleo, Ana; Xiong, Ma; Gershwin, M. Eric; Invernizzi, Pietro
Long noncoding RNA HOTTIP/HOXA13 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients
2014-01-01 Quagliata, Luca; Matter, Matthias S; Piscuoglio, Salvatore; Arabi, Leila; Ruiz, Christian; Procino, Alfredo; Kovac, Michal; Moretti, Francesca; Makowska, Zuzanna; Boldanova, Tujana; Andersen, Jesper B; Hämmerle, Monika; Tornillo, Luigi; Heim, Markus H; Diederichs, Sven; Cillo, Clemente; Terracciano, Luigi M
Low Rates of Naturally Occurring Resistant Variants to the NS5A Inhibitor Daclatasvir in HCV-1 Null Responders
2013-01-01 Galmozzi, E; Aghemo, A; Colombo, M
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Human leukocyte antigen polymorphisms in Italian primary biliary cirrhosis : a multicenter study of 664 patients and 1992 healthy controls | 1-gen-2008 | Invernizzi, P.; Selmi, C.; Poli, F.; Frison, S.; Floreani, A.; Alvaro, D.; Almasio, P.; Rosina, F.; Marzioni, M.; Fabris, L.; Muratori, L.; Qi, L.; Seldin, M. F.; Gershwin, M. E.; Podda, M.; Andreoletti, M.; Andriulli, A.; Baldini, V.; Battezzati, P. M.; Benedetti, A.; Bernuzzi, F.; Bianchi, F. B.; Bianchi, I.; Bignotto, M.; Bragazzi, M. C.; Brunetto, M.; Caimi, M.; Caliari, L.; Caporaso, N.; Casella, G.; Casiraghi, A.; Colli, A.; Colombo, M.; Conte, D.; Croce, L.; Crosignani, A.; Dottorini, L.; Ferrari, C.; Fraquelli, M.; Frati, C. E.; Galli, A.; Lleo, A.; Mancino, M. G.; Mandelli, G.; Marra, F.; Montanari, R.; Monti, V.; Morini, L.; Morisco, F.; Niro, G.; Palasciano, G.; Calmieri, V. O.; Pasini, S.; Picciotto, A.; Portincasa, P.; Pozzoli, V.; Spinzi, G.; Strazzabosco, M.; Tiribelli, C.; Toniutto, P.; Zerminai, P.; Zuin, M. | |
| IMMUNE CHANGES DURING THE EARLY STEPS OF HUMAN LIVER CARCINOGENESIS | 1-gen-2019 | Meylan, M; Petitprez, F; Lacroix, L; Di Tommaso, L; Roncalli, M; Pawlotsky, Jm; Fridman, C; Fridman, Wh; Calderaro, J | |
| Immunoglobulin M levels inversely correlate with CD40 ligand promoter methylation in patients with primary biliary cirrhosis | 1-gen-2012 | Lleo, A; Liao, J; Invernizzi, P; Zhao, M; Bernuzzi, F; L, Ma; Lanzi, G; Ansari, Aa; Coppel, Rl; Zhang, P; Y, Li; Zhou, Z; Lu Q and Gershwin, Me. | |
| Impaired intrahepatic natural killer cell cytotoxic function in chronic hepatitis C virus infection | 1-gen-2012 | Varchetta, S.; Mele, D.; Mantovani, S.; Oliviero, B.; Cremonesi, E.; Ludovisi, S.; Michelone, G.; Alessiani, M.; Rosati, R.; Montorsi, M.; Mondelli, M. U. | |
| Impairment of hepatic growth hormone and glucocorticoid receptor signaling causes steatosis and hepatocellular carcinoma in mice. | 1-gen-2011 | Mueller, Km; Kornfeld, Jw; Friedbichler, K; Blaas, L; Egger, G; Esterbauer, H; Hasselblatt, P; Schlederer, M; Haindl, S; Wagner, Ku; Engblom, D; Haemmerle, G; Kratky, D; Sexl, V; Kenner, L; Kozlov, Av; Terracciano, L; Zechner, R; Schuetz, G; Casanova, E; Pospisilik, Ja; Heim, Mh; Moriggl, R | |
| Increased risk of hepatocellular carcinoma in HCV (+) non responder cirrhotics with high liver cell proliferation | 1-gen-2008 | Donato, M. F.; Arosio, E.; Aghemo, A.; Rumi, M. G.; Ronchi, G.; Colombo, M. | |
| Inducible inactivation of Notch1 causes nodular regenerative hyperplasia in mice | 1-gen-2005 | Croquelois, A; Blindenbacher, A; Terracciano, L; Wang, X; Langer, I; Radtke, F; Heim, Mh. | |
| Interleukin 28B polymorphism predicts pegylated interferon plus ribavirin treatment outcome in chronic hepatitis C genotype 4 | 1-gen-2012 | De Nicola, S; Aghemo, A; Rumi, Mg; Galmozzi, E; Valenti, L; Soffredini, R; De Francesco, R; Prati, Gm; D'Ambrosio, R; Cheroni, C; Donato, Mf; Colombo, M | |
| Interleukin 6 is important for survival after partial hepatectomy in mice | 1-gen-2003 | Blindenbacher, A; Wang, X; Langer, I; Savino, R; Terracciano, L; Heim, Mh | |
| Is there need for more than one IL28B single nucleotide polymorphism in hepatitis C clinical practice? | 1-gen-2013 | Galmozzi, E; De Nicola, S; Aghemo, A; Colombo, M | |
| JNJ-4178 (AL-335, Odalasvir, and Simeprevir) for 6 or 8 Weeks in Hepatitis C Virus-Infected Patients Without Cirrhosis: OMEGA-1 | 1-gen-2019 | Zeuzem, S; Bourgeois, S; Greenbloom, S; Buti, M; Aghemo, A; Lampertico, P; Janczewska, E; Lim, Sg; Moreno, C; Buggisch, P; Tam, E; Corbett, C; Willems, W; Vijgen, L; Fevery, B; Ouwerkerk-Mahadevan, S; Ackaert, O; Beumont, M; Kalmeijer, R; Sinha, R; Biermer, M | |
| Keratin variants are overrepresented in primary biliary cirrhosis and associate with disease severity | 1-gen-2009 | Zhong, B.; Strnad, P.; Selmi, C.; Invernizzi, P.; Tao, G. Z.; Caleffi, A.; Chen, M.; Bianchi, I.; Podda, M.; Pietrangelo, A.; Gershwin, M. E.; Omary, M. B. | |
| Lack of alanine aminotransferase normalization in patients with an anti-hcv virological response during pegylated interferon and ribavirin therapy : a sub-analysis of the mist study | 1-gen-2009 | Aghemo, A.; Rumi, M.; Prati, G. M.; D’Ambrosio, R.; De Nicola, S.; Colombo, M. | |
| Lack of complete biochemical response in autoimmune hepatitis leads to adverse outcome: first report of the IAIHG retrospective registry | 1-gen-2023 | Slooter, Charlotte D; van den Brand, Floris F; Lleo, Ana; Colapietro, Francesca; Lenzi, Marco; Muratori, Paolo; Kerkar, Nanda; Dalekos, George N; Zachou, Kalliopi; Lucena, M Isabel; Robles-Díaz, Mercedes; Di Zeo-Sánchez, Daniel E; Andrade, Raúl J; Montano-Loza, Aldo J; Lytvyak, Ellina; Lissenberg-Witte, Birgit I; Maisonneuve, Patrick; Bouma, Gerd; Macedo, Guilherme; Liberal, Rodrigo; de Boer, Ynto S | |
| Large liver cell change in hepatitis B virus-related liver cirrhosis | 1-gen-2009 | Kim, H.; Oh, B. K.; Roncalli, M.; Park, C.; Yoon, S. M.; Yoo, J. E.; Park, Y. N. | |
| Letter to the Editor: Are We Confident That Primary Biliary Cholangitis Liver‐Related Mortality Is Higher in Males? | 1-gen-2021 | Lleo, Ana; Hirschfield, Gideon M. | |
| Letter to the Editor: might denosumab fit in PBC treatment? | 1-gen-2019 | Lleo, A; Ma, X; Gershwin, Me; Invernizzi, P | |
| Letter to the Editor: Might Denosumab Fit in Primary Biliary Cholangitis Treatment? | 1-gen-2020 | Lleo, Ana; Xiong, Ma; Gershwin, M. Eric; Invernizzi, Pietro | |
| Long noncoding RNA HOTTIP/HOXA13 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients | 1-gen-2014 | Quagliata, Luca; Matter, Matthias S; Piscuoglio, Salvatore; Arabi, Leila; Ruiz, Christian; Procino, Alfredo; Kovac, Michal; Moretti, Francesca; Makowska, Zuzanna; Boldanova, Tujana; Andersen, Jesper B; Hämmerle, Monika; Tornillo, Luigi; Heim, Markus H; Diederichs, Sven; Cillo, Clemente; Terracciano, Luigi M | |
| Low Rates of Naturally Occurring Resistant Variants to the NS5A Inhibitor Daclatasvir in HCV-1 Null Responders | 1-gen-2013 | Galmozzi, E; Aghemo, A; Colombo, M |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile